CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-3,691 Cr | ₹-2,988 Cr | ₹-2,389 Cr | ₹-1,872 Cr | ₹-2,387 Cr |
What is the latest Cash Flow from Investing Activities ratio of CIPLA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-3,691 Cr |
| Mar2024 | ₹-2,988 Cr |
| Mar2023 | ₹-2,389 Cr |
| Mar2022 | ₹-1,872 Cr |
| Mar2021 | ₹-2,387 Cr |
How is Cash Flow from Investing Activities of CIPLA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-3,691 Cr | Negative | |
| Mar2024 | ₹-2,988 Cr | Negative | |
| Mar2023 | ₹-2,389 Cr | Negative | |
| Mar2022 | ₹-1,872 Cr | Negative | |
| Mar2021 | ₹-2,387 Cr | - | |
Compare Cash Flow from Investing Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,515.8 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
| MANKIND PHARMA | ₹85,198.8 Cr | 0.5% | -4.3% | -17.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1% |
-3% |
-8.7% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses